foxo4-dri p53 The disordered transactivation domain is the target of FOXO4 and the senolytic compound Figure 5 — FOXO4-DRI alleviates
Figure 5 FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging FOXO4 DRI Excenen PharmaTech FOXO4 an overview ScienceDirect Topics Senescent Cells Their Role in Kidney Disease Kidney Coach Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




